Cancer Immunology, Immunotherapy 2015-09-01

Inhibition of tumor progression during allergic airway inflammation in a murine model: significant role of TGF-β.

Belen Tirado-Rodriguez, Guillermina Baay-Guzman, Rogelio Hernandez-Pando, Gabriela Antonio-Andres, Mario I Vega, Leticia Rocha-Zavaleta, Laura C Bonifaz, Sara Huerta-Yepez

Index: Cancer Immunol. Immunother. 64 , 1205-14, (2015)

Full Text: HTML

Abstract

TGF-β is an important mediator of pulmonary allergic inflammation, and it has been recently reported to be a potential inhibitor of lung tumor progression. The correlation between cancer and allergic inflammatory diseases remains controversial. Thus, the aim of the present study was to evaluate the effects of pulmonary allergic inflammation and in particular the role of TGF-β on cancer progression.Cancer cells were implanted in a BALB/c mice model of allergic airway inflammation, and tumor growth was measured. Apoptosis was evaluated by TUNEL assay, and TGF-β was measured by ELISA. Expression of proliferating cell nuclear antigen, TGF-β, TGF-β receptors I and II, phospho-Smad2 and phospho-Smad4 was evaluated by immunohistochemistry and quantified using digital pathology. The effect of a TGF-β activity inhibitor and recombinant TGF-β on tumor growth was analyzed. The effect of exogenous TGF-β on cell proliferation and apoptosis was evaluated in vitro.Mice with allergic airway inflammation exhibited decreased tumor volumes due to cell proliferation inhibition and increased apoptosis. TGF-β was increased in the sera and tumor tissues of allergic mice. TGF-β activity inhibition increased tumor progression in allergic mice by enhancing proliferation and decreasing apoptosis of tumor cells. The administration of TGF-β resulted in reduced tumor growth.This study is the first to establish an inverse relationship between allergic airway inflammation and tumor progression. This effect appears to be mediated by TGF-β, which is overexpressed in tumor cells during pulmonary allergic inflammation. This study indicates that TGF-β is a potential target for antitumor therapy.


Related Compounds

Related Articles:

A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis.

2015-04-01

[Angiogenesis 18(2) , 209-17, (2015)]

Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.

2015-01-01

[Drug Des. Devel. Ther. 9 , 1555-84, (2015)]

Analysis of cytochrome P450 CYP119 ligand-dependent conformational dynamics by two-dimensional NMR and X-ray crystallography.

2015-04-17

[J. Biol. Chem. 290(16) , 10000-17, (2015)]

An HD-domain phosphodiesterase mediates cooperative hydrolysis of c-di-AMP to affect bacterial growth and virulence.

2015-02-17

[Proc. Natl. Acad. Sci. U. S. A. 112(7) , E747-56, (2015)]

Dominant Rio1 kinase/ATPase catalytic mutant induces trapping of late pre-40S biogenesis factors in 80S-like ribosomes.

2014-07-01

[Nucleic Acids Res. 42(13) , 8635-47, (2014)]

More Articles...